Rybelsus Tracker App
Track Your Rybelsus Protocol
Rybelsus (Semaglutide (oral)) is an oral glp-1, FDA approved, used in PIONEER with ~4.4 kg weight loss at 52 weeks. Shotlee is the free app to track your complete Rybelsus protocol — doses, side effects, weight, and labs.
What Is Rybelsus?
Rybelsus (Semaglutide (oral)) is an oral glp-1, FDA approved, used in PIONEER with ~4.4 kg weight loss at 52 weeks. Shotlee is the free app to track your complete Rybelsus protocol — doses, side effects, weight, and labs.
Shotlee tracks every aspect of your Rybelsus protocol: injection dates, doses, sites, side effects, weight changes, and lab results. Whether you are starting or optimizing, clean data makes better decisions.
What to Track in Shotlee
Build a complete Rybelsus protocol record from day one.
How to Track Your Rybelsus Protocol
Rybelsus Key Facts
Protocol FAQs
Log each injection in Shotlee with the dose, date, injection site, and any side effects. Shotlee keeps a complete timeline of your Rybelsus protocol.
Yes. Shotlee supports tracking multiple medications and peptides simultaneously, including combination protocols.
Record every dose, injection site, timing, any side effects, and weekly weight/measurements. This data helps you and your prescriber optimize your protocol.
Yes. Shotlee is completely free for dose logging, side effect tracking, and protocol management. No hidden fees.
Open the Shotlee app, navigate to the dose logging screen, select Oral Semaglutide as your medication, and enter the dose amount, injection site, and time. Shotlee stores all entries with timestamps and lets you view your complete dose history, adherence rate, and missed dose alerts. The app is free to download and use.
The most important side effects to track include gastrointestinal symptoms (nausea, vomiting, diarrhea, constipation), injection site reactions, appetite changes, energy levels, and any unusual symptoms. Log these daily in Shotlee so you can share accurate trend data with your healthcare provider at your next visit.
Most patients begin noticing appetite changes within the first one to two weeks. Measurable weight loss typically becomes apparent by weeks four to eight, depending on the dose titration schedule and individual metabolic response. Track your weekly weight in Shotlee to visualize your personal response curve over time.
Track Your Rybelsus Protocol in Shotlee
Free dose logs, side effect tracking, weight trends, and lab results — all in one app.
📚References & sources
Latest on Semaglutide (oral)
Plus-Size Swimsuit Model on Inclusivity Amidst GLP-1 Medications
Plus-size model Hunter McGrady shares her concerns about a perceived decline in fashion inclusivity, particularly in the context of the growing popularity of GLP-1 weight loss medications.
7 min read
Black-Market Peptide Surge Strains Needle and Syringe Programs
The rise of unregulated peptides for performance and image enhancement is placing significant pressure on vital harm reduction services, originally established to combat HIV. These programs are now facing increased demand and potential shortages of essential supplies.
7 min read
Which GLP-1 Works Best? New Meta-Study Puts Medications Head-to-Head
A comprehensive meta-analysis from the University of Georgia compares three major GLP-1 medications. Discover which drug offers the highest weight loss efficacy and what the data means for patients.
8 min read